Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases for candidates for therapy with tumor necrosis factor alpha inhibitors--March 2008 update.
Eurico Fonseca J, Lucas H, Canhão H, Duarte R, José Santos M, Villar M, Faustino A, Raymundo E; Rheumatoid Arthritis Study Group of Portuguese Society of Rheumatology. Eurico Fonseca J, et al. Among authors: raymundo e. Rev Port Pneumol. 2008 Mar-Apr;14(2):271-83. Rev Port Pneumol. 2008. PMID: 18564448 Free article.
[Recommendations for the diagnosis and treatment of latent and active tuberculosis in patients with inflammatory joint diseases treated with tumour necrosis factor alpha inhibitors].
Fonseca JE, Lucas H, Canhão H, Duarte R, Santos MJ, Villar M, Faustino A, Raymundo E; Grupo de Estudos de Artrite Reumatóide da Sociedade Portuguesta de Reumatologia; Comissão de Tuberculose da Sociedade Portuguesa de Pneumologia. Fonseca JE, et al. Among authors: raymundo e. Acta Reumatol Port. 2006 Jul-Sep;31(3):237-45. Acta Reumatol Port. 2006. PMID: 17094335 Free article. Portuguese.
[Guidelines for the diagnosis and treatment of latent tuberculosis infection and active tuberculosis in patients with inflammatory joint diseases proposed for treatment with tumour necrosis factor alpha antagonist drugs].
Fonseca JE, Lucas H, Canhão H, Duarte R, Santos MJ, Villar M, Faustino A, Raymundo E; Sociedade Portuguesa de Reumatologia; Sociedade Portuguesa de Pneumologia. Fonseca JE, et al. Among authors: raymundo e. Rev Port Pneumol. 2006 Sep-Oct;12(5):603-13. Rev Port Pneumol. 2006. PMID: 17117328 Review. Portuguese.
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors - March 2008 update.
Fonseca JE, Lucas H, Canhão H, Duarte R, Santos MJ, Villar M, Faustino A, Raymundo E. Fonseca JE, et al. Among authors: raymundo e. Rev Port Pneumol. 2008 Mar-Apr;14(2):271-83. doi: 10.1016/S0873-2159(15)30235-X. Rev Port Pneumol. 2008. PMID: 25966834 Free article. English, Portuguese.
Anti-tuberculosis drug resistance in Portugal.
Antunes ML, Aleixo-Dias J, Antunes AF, Pereira MF, Raymundo E, Rodrigues MF. Antunes ML, et al. Among authors: raymundo e. Int J Tuberc Lung Dis. 2000 Mar;4(3):223-31. Int J Tuberc Lung Dis. 2000. PMID: 10751067
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.
Paller AS, Mendes-Bastos P, Siegfried E, Eichenfield LF, Soong W, Prajapati VH, Lio P, Simpson EL, Raymundo EM, Suravaram S, Hu X, Yang Y, Huang X, Calimlim BM, Platt AM, Su JC, Zheng M, Yamamoto-Hanada K, Teixeira HD, Irvine AD. Paller AS, et al. Among authors: raymundo em. JAMA Dermatol. 2024 Dec 1;160(12):1304-1313. doi: 10.1001/jamadermatol.2024.3696. JAMA Dermatol. 2024. PMID: 39441580 Free PMC article. Clinical Trial.
24 results